Fund Holdings — TAKEDA PHARMACEUTICAL CO LTD

Total Portfolio Value:
$16.37M
Total Bought:
$527.5K
Total Sold:
$13.90M
Net Transaction:
-$13.38M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Ovid Therapeutics Inc.(OVID)7,531,9967,531,9960$2.49M$9.79M59.82%+$7.31M
Equillium, Inc.(EQ)1,824,9771,824,9770$575.2K$2.61M15.94%+$2.03M
Xilio Therapeutics, Inc.(XLO)1,475,1211,475,1210$1.00M$1.24M7.59%+$240.1K
Shattuck Labs, Inc.(STTK)515,619515,6190$408.3K$1.23M7.53%+$824.1K
Lyell Immunopharma, Inc.(LYEL)41,16554,887+13,722$363.9K$891.4K5.45%+$527.5K
American Well Corporation(AMWL)77,73377,7330$691.0K$478.1K2.92%-$213.0K
Rani Therapeutics Holdings, Inc.(RANI)203,190203,1900$104.4K$101.6K0.62%-$2.9K
Standard BioTools Inc.(LAB)16,51516,5150$19.8K$21.5K0.13%+$1.7K
Turnstone Biologics895,8240-895,824$321.6K$0—-$321.6K
Third Harmonic Bio, Inc.36,8350-36,835$200.0K$0—-$200.0K
HilleVax, Inc.6,724,0000-6,724,000$13.38M$0—-$13.38M
Page 1 of 1
TAKEDA PHARMACEUTICAL CO LTD — 13F Holdings — Q3 2025 | TickerTrail